Learn More
Medchemexpress LLC N-(5-(((4-Me-1,2,5-thiadiazol-3-yl)thio)methyl)-1,3,4-thiadiazol-2-yl)-4-(4-(CF3)Ph)thiazol-2-amine | 2809469-05-2 | 99.0% | 501.56 g·mol⁻¹ | C21H18F3NO4S3 | 100 MG

Supplier: Medchemexpress LLC HY103693100MG
NAZ2329 is a research-grade, cell-permeable small-molecule inhibitor that allosterically and preferentially targets the receptor-type protein tyrosine phosphatases PTPRZ and PTPRG. It has demonstrated inhibition of glioblastoma cell growth and suppression of stem cell-like properties in published studies. Supplied as a purified powder for laboratory research use.
- Allosteric inhibitor of PTPRZ and PTPRG.
- Demonstrated antiproliferative activity in glioblastoma models.
- High reported purity (99.02%).
- Soluble in DMSO (100 mg/mL); in vivo formulation protocols available.
- Recommended storage: powder at -20 °C for long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.